Center for Stroke Research Berlin (CSB) Prospective Stroke Cohort (CSB_PROSCIS)
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Peter U Heuschmann, MD, MPH
- Phone Number: 0049 (0)30 450560611
- Email: peter.heuschmann@charite.dwe
Study Contact Backup
- Name: Thomas G Liman, MD
- Phone Number: 49 (0)30 450560643
- Email: thomas.liman@charite.de
Study Locations
-
-
-
Berlin, Germany, 10117
- Recruiting
- Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin
-
Contact:
- Peter U Heuschmann, MD, MPH
- Phone Number: +49 (0)30 450560611
- Email: peter.heuschmann@charite.de
-
Contact:
- Thomas G Liman, MD
- Phone Number: +49 (0)30 450560643
- Email: thomas.liman@charite.de
-
Principal Investigator:
- Peter U Heuschmann, MD, MPH
-
Munich, Germany
- Recruiting
- Interdisciplinary Stroke Center Munich, Klinikum der Universität München, Campus Großhadern
-
Contact:
- Martin Dichgans, MD
- Phone Number: +49 (0)89 7095 Ext. 8310
- Email: martin.dichgans@med.uni-muenchen.de
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥18 years
- Language: German
- First ever stroke including ischemic stroke, primary intracranial hemorrhage and cerebral venous sinus thrombosis that occurred with stroke onset in the last 7 days
- Written informed consent by patient prior to study participation
- Willingness to participate in follow-up
Exclusion Criteria:
- Prior stroke (definition according to WHO definition)
- Patients presenting brain tumour or brain metastasis
- Participation in an intervention- / AMG-study
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
First ever acute stroke
Patients over 18 years and without prior stroke according to WHO criteria, displaying an ischemic stroke, onset within the last 7 days, language German
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Combined vascular endpoint composed of stroke, myocardial infarction, and vascular death
Time Frame: 36 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by hospital or physician.
|
36 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Combined vascular endpoint composed of stroke, myocardial infarction, and vascular death
Time Frame: 24 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by hospital or physician.
In case of death of the patient, evaluation will be based on data from the registry office
|
24 months
|
|
Combined vascular endpoint composed of stroke, myocardial infarction, and vascular death
Time Frame: 12 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by hospital or physician.
In case of death of the patient, evaluation will be based on data from the registry office
|
12 months
|
|
Course of cognitive function
Time Frame: 36 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by the physician
|
36 months
|
|
Course of depression
Time Frame: 36 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by the physician
|
36 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Peter U Heuschmann, MD MPH, Center for Stroke Research Berlin, Charité Campus Mitte
Publications and helpful links
General Publications
- Stillfried MRV, Sperber PS, Broersen LHA, Huo S, Piper SK, Heuschmann PU, Endres M, Siegerink B, Liman TG. Low ankle-brachial index and cognitive function after stroke-the PROSpective with Incident Stroke Berlin (PROSCIS-B). Front Neurol. 2022 Sep 28;13:963262. doi: 10.3389/fneur.2022.963262. eCollection 2022.
- Scheitz JF, Lim J, Broersen LHA, Ganeshan R, Huo S, Sperber PS, Piper SK, Heuschmann PU, Audebert HJ, Nolte CH, Siegerink B, Endres M, Liman TG. High-Sensitivity Cardiac Troponin T and Recurrent Vascular Events After First Ischemic Stroke. J Am Heart Assoc. 2021 May 18;10(10):e018326. doi: 10.1161/JAHA.120.018326. Epub 2021 May 13.
- Huo S, Krankel N, Nave AH, Sperber PS, Rohmann JL, Piper SK, Heuschmann PU, Landmesser U, Endres M, Siegerink B, Liman TG. Endothelial and Leukocyte-Derived Microvesicles and Cardiovascular Risk After Stroke: PROSCIS-B. Neurology. 2021 Feb 9;96(6):e937-e946. doi: 10.1212/WNL.0000000000011223. Epub 2020 Nov 12.
- Broersen LHA, Siegerink B, Sperber PS, von Rennenberg R, Piper SK, Nolte CH, Heuschmann PU, Endres M, Scheitz JF, Liman TG. High-Sensitivity Cardiac Troponin T and Cognitive Function in Patients With Ischemic Stroke. Stroke. 2020 May;51(5):1604-1607. doi: 10.1161/STROKEAHA.119.028410. Epub 2020 Apr 13.
- Sperber PS, Siegerink B, Huo S, Rohmann JL, Piper SK, Pruss H, Heuschmann PU, Endres M, Liman TG. Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B). Stroke. 2019 Nov;50(11):3213-3219. doi: 10.1161/STROKEAHA.119.026100. Epub 2019 Sep 17. Erratum In: Stroke. 2019 Nov;50(11):e343.
- Liman TG, Zietemann V, Wiedmann S, Jungehuelsing GJ, Endres M, Wollenweber FA, Wellwood I, Dichgans M, Heuschmann PU. Prediction of vascular risk after stroke - protocol and pilot data of the Prospective Cohort with Incident Stroke (PROSCIS). Int J Stroke. 2013 Aug;8(6):484-90. doi: 10.1111/j.1747-4949.2012.00871.x. Epub 2012 Aug 29.
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CSB_PROSCIS_01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.